Diarylethene-Based Photoswitchable Inhibitors of Serine Proteases

Angew Chem Int Ed Engl. 2021 Sep 27;60(40):21789-21794. doi: 10.1002/anie.202108847. Epub 2021 Aug 25.

Abstract

A bicyclic peptide scaffold was chemically adapted to generate diarylethene-based photoswitchable inhibitors of serine protease Bos taurus trypsin 1 (T1). Starting from a prototype molecule-sunflower trypsin inhibitor-1 (SFTI-1)-we obtained light-controllable inhibitors of T1 with Ki in the low nanomolar range, whose activity could be modulated over 20-fold by irradiation. The inhibitory potency as well as resistance to proteolytic degradation were systematically studied on a series of 17 SFTI-1 analogues. The hydrogen bond network that stabilizes the structure of inhibitors and possibly the enzyme-inhibitor binding dynamics were affected by isomerization of the photoswitch. The feasibility of manipulating enzyme activity in time and space was demonstrated by controlled digestion of gelatin-based hydrogel and an antimicrobial peptide BP100-RW. Finally, our design principles of diarylethene photoswitches are shown to apply also for the development of other serine protease inhibitors.

Keywords: bicyclic peptide; diarylethene photoswitch; hydrogel photoregulation; serine protease inhibitors; trypsin.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cattle
  • Ethylenes / chemistry
  • Ethylenes / pharmacology*
  • Molecular Structure
  • Peptides, Cyclic / chemistry
  • Peptides, Cyclic / pharmacology*
  • Serine Proteases / metabolism*
  • Serine Proteinase Inhibitors / chemistry
  • Serine Proteinase Inhibitors / pharmacology*

Substances

  • Ethylenes
  • Peptides, Cyclic
  • Serine Proteinase Inhibitors
  • ethylene
  • Serine Proteases